• In January 2026, Altria Group reported fourth-quarter and full-year 2025 results showing lower sales and net income, a US$285 million goodwill impairment, completion of a US$1.00 billion share repurchase program, and the election of incoming CEO Salvatore Mancuso to an expanded 12-member board.
• Despite the profit pressure, Altria continued to prioritize shareholder returns through dividend growth and buybacks, even as it prepares for a leadership transition later in 2026.
• We’ll now examine how Altria’s earnings decline alongside ongoing buybacks and dividend focus affects its existing investment narrative.

The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Altria Group Investment Narrative Recap

To own Altria today, you have to believe its core U.S. nicotine franchises can keep generating substantial cash, even as cigarette volumes and margins come under pressure. The latest results, with lower sales, sharply lower net income and a US$285 million goodwill impairment, highlight that earnings pressure is already real. In the near term, the key catalyst remains management’s ability to defend profitability while expanding smoke free offerings, while the biggest risk is that regulatory and competitive shocks further squeeze already stressed earnings.

Among the recent announcements, the completion of the US$1.00 billion share repurchase program stands out in light of weaker 2025 earnings. Continuing buybacks and dividend growth while net income falls and the dividend payout ratio exceeds 100% of earnings puts even more focus on Altria’s cash generation and balance sheet. For investors who see buybacks as supportive of per share metrics, this program interacts directly with both the earnings risk and the near term income catalyst.

Yet beneath the headline of strong cash returns to shareholders, investors should be aware of...

Altria Group's narrative projects $20.3 billion revenue and $9.1 billion earnings by 2028. This implies a 0.1% yearly revenue decline and a $1.1 billion earnings decrease from $10.2 billion today.

Uncover how Altria Group's forecasts yield a $63.83 fair value, a 3% downside to its current price.

Exploring Other Perspectives

Before this earnings miss and impairment, the most optimistic analysts were still modeling revenue drifting to about US$20.9 billion and earnings near US$9.2 billion by 2028, which showed how differently you and other investors might view Altria’s smoke free push and illicit e vapor risks once this new information is fully reflected in those forecasts.

Explore 10 other fair value estimates on Altria Group - why the stock might be worth as much as 73% more than the current price!

Build Your Own Altria Group Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Altria Group research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Altria Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Altria Group's overall financial health at a glance.

Want Some Alternatives?

Our top stock finds are flying under the radar-for now. Get in early:

• Invest in the nuclear renaissance through our list of 87 elite nuclear energy infrastructure plays powering the global AI revolution.
• Rare earth metals are the new gold rush. Find out which 32 stocks are leading the charge.
• Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.